Ionis Pharmaceuticals in (ions 0.125 12/15/24)
13F holders, Q3 2024 (September 30)2holders −1
0new positions
1sold out
$0.98avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Ionis Pharmaceuticals in (ions 0.125 12/15/24) in their 13F filings, down 1 from Q2 2024. 0 opened new positions and 1 sold out. The largest holders were Sonora Investment Management Group, LLC ($13.9M) and Kestra Private Wealth Services, LLC ($20K).
- Company
- Ionis Pharmaceuticals in (ions 0.125 12/15/24)
- CUSIP
- 462222AB6
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $10K |
All 13F filers, Q2 2024 → Q3 2024: 1,568,000 shares sold, net −1,568,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Sonora Investment Management Group, LLC | 1.04% | Reduce -9.9% | 14,183,000 | $13.9M |
| Kestra Private Wealth Services, LLC | 0.00% | No change | 20,000 | $20K |
"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 0.125 12/15/24)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 0.125 12/15/24) the manager owns.